- Home
- NMM vs PRCT Comparison
NMM vs PRCT Comparison
Compare NMM & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NMM | PRCT |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NMM | PRCT |
|---|---|---|
| Price | $67.70 | $26.19 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $35.44 |
| AVG Volume (30 Days) | 186.9K | ★ 2.1M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | $5.64 | $32.85 |
| Revenue Next Year | $4.30 | $24.66 |
| P/E Ratio | $7.24 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $28.37 | $19.35 |
| 52 Week High | $74.21 | $64.89 |
Technical Indicators
Market Signals| Indicator | NMM | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 57.10 | 47.20 |
| Support Level | $49.57 | $19.35 |
| Resistance Level | $74.21 | $29.24 |
| Average True Range (ATR) | 2.79 | 1.90 |
| MACD | -0.71 | 0.33 |
| Stochastic Oscillator | 59.08 | 63.47 |
Price Performance
Historical ComparisonAbout NMM Navios Maritime Partners LP
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through the chartering of vessels and voyage contracts. Geographically, it generates majority revenue from Asia.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.